Search results
Showing 76 to 90 of 128 results for urinary incontinence
Cerebral palsy in under 25s: assessment and management (NG62)
This guideline covers diagnosing, assessing and managing cerebral palsy in children and young people from birth up to their 25th birthday. It aims to make sure they get the care and treatment they need for the developmental and clinical comorbidities associated with cerebral palsy, so that they can be as active and independent as possible.
Source guidance details Comes from guidance Urinary incontinence and pelvic organ prolapse in women: management Number
augmentation cystoplasty in people with primary cerebral conditions with lower urinary tract dysfunction? Any explanatory notes(if...
Source guidance details Comes from guidance Urinary incontinence and pelvic organ prolapse in women: management Number
Source guidance details Comes from guidance Urinary incontinence and pelvic organ prolapse in women: management Number
Source guidance details Comes from guidance Urinary incontinence and pelvic organ prolapse in women: management Number
Transient loss of consciousness ('blackouts') in over 16s (CG109)
This guideline covers assessment, diagnosis and referral for people over 16 who have had a transient loss of consciousness (TLoC; also called a blackout). It aims to improve care for people with TLoC by specifying the most effective assessments and recommending when to refer to a specialist.
Autism spectrum disorder in under 19s: recognition, referral and diagnosis (CG128)
This guideline covers recognising and diagnosing autism spectrum disorder in children and young people from birth up to 19 years. It also covers referral. It aims to improve the experience of children, young people and those who care for them.
In virtual wards, people can receive virtual and technology-assisted treatment, assessment, and monitoring.
Axonics sacral neuromodulation system for treating refractory overactive bladder (HTG554)
Evidence-based recommendations on Axonics sacral neuromodulation system for treating refractory overactive bladder.
Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia (HTG545)
Evidence-based recommendations on Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia.
care and (b) other antimuscarinics in the treatment of neurogenic lower urinary tract dysfunction? Any explanatory notes(if applicable)...
Focal therapy using high-intensity focused ultrasound for localised prostate cancer (HTG667)
Evidence-based recommendations on focal therapy using high-intensity focused ultrasound for localised prostate cancer. This involves using high-intensity focused ultrasound to heat up and destroy only the areas of the prostate with cancer (focal therapy). The aim is to destroy the cancer while reducing damage to healthy prostate tissue.
View recommendations for HTG667Show all sections
on quality of life of different bladder management strategies for lower urinary tract dysfunction in people with neurological disease?...
UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia (HTG578)
Evidence-based recommendations on UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia.